4.5 Editorial Material

The NLRP3 Inflammasome and Diabetic Cardiomyopathy

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model

Beibei Luo et al.

CARDIOVASCULAR DRUGS AND THERAPY (2014)

Review Endocrinology & Metabolism

NLRP3 and IL-1β in macrophages as critical regulators of metabolic diseases

A. F. McGettrick et al.

DIABETES OBESITY & METABOLISM (2013)

Article Biochemistry & Molecular Biology

Thioredoxin-interacting protein regulates insulin transcription through microRNA-204

Guanlan Xu et al.

NATURE MEDICINE (2013)

Review Immunology

Unsolved mysteries in NLR biology

Christopher Lupfer et al.

FRONTIERS IN IMMUNOLOGY (2013)

Article Immunology

The NLRP3/ASC/Caspase-1 axis regulates IL-1ß processing in neutrophils

Arun K. Mankan et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2012)

Article Neurosciences

TXNIP in Agrp Neurons Regulates Adiposity, Energy Expenditure, and Central Leptin Sensitivity

Clemence Blouet et al.

JOURNAL OF NEUROSCIENCE (2012)

Review Biotechnology & Applied Microbiology

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

Charles A. Dinarello et al.

NATURE REVIEWS DRUG DISCOVERY (2012)

Article Endocrinology & Metabolism

Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein

Junqin Chen et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)